ANVISA registration 10341351026Valid until Oct 09, 2033DRUG-ELUTING STENT FOR CORONARY ARTERIES
ANVISA Registration Number: 10341351026BOSTON SCIENTIFIC DO BRASIL LTDABOSTON SCIENTIFIC CORPORATIONRisk Class IV
Device names
- Technical name
- DRUG-ELUTING STENT FOR CORONARY ARTERIES
- Commercial name
- Synergy Megatron Monorail - Sistema de stent coronário de platina-cromo com eluição de everolimus
- Risk class
- Class IV
PT: STENT FARMACOLÓGICO PARA ARTÉRIAS CORONÁRIAS
Registration details
- Registration Number
- 10341351026
- Process Number
- 25351406382202246
- CNPJ
- 01513946000114
Company information
- Registration Holder
- BOSTON SCIENTIFIC DO BRASIL LTDA
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Manufacturing Country
- United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
- Publication Date
- Oct 09, 2023
- Validity
- 09/10/2033
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for DRUG-ELUTING STENT FOR CORONARY ARTERIES in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10341351026 and manufactured by BOSTON SCIENTIFIC CORPORATION. The registration is held by BOSTON SCIENTIFIC DO BRASIL LTDA with validity until Oct 09, 2033.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.